Replies to post #89 on Precision BioSciences Inc (DTIL)

[jondoeuk]

I do think they should focus on their so-called stealth cells, so by the end of the year look to stop the PBCAR019 trial and focus on PBCAR019B. They also have another four targets https://www.businesswire.com/news/home/20210415005982/en/Precision-BioSciences-Reacquires-Global-Rights-to-its-Allogeneic-CAR-T-Programs

So make an assessment of them and maybe look to move PBCAR371A* into the clinic.

* An anti-CLL-1 CAR-T